MLN2704 / Takeda  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MLN2704 / Takeda
NCT00052000: A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Completed
1
29
US
MLN2704 (DM1 conjugated monoclonal antibody MLN591)
Millennium Pharmaceuticals, Inc.
Prostate Cancer
 
 

Download Options